Clinical trials
Completed Hypogonadism trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
213 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 4 |
| 2002 | 6 |
| 2003 | 2 |
| 2004 | 13 |
| 2005 | 10 |
| 2006 | 16 |
| 2007 | 13 |
| 2008 | 15 |
| 2009 | 13 |
| 2010 | 11 |
| 2011 | 9 |
| 2012 | 13 |
| 2013 | 13 |
| 2014 | 17 |
| 2015 | 5 |
| 2016 | 13 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 213 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Repros Therapeutics Inc. | 16 |
| Gulhane School of Medicine | 10 |
| Massachusetts General Hospital | 9 |
| Clarus Therapeutics, Inc. | 7 |
| Eli Lilly and Company | 6 |
| Antares Pharma Inc. | 5 |
| Bayer | 5 |
| Acerus Pharmaceuticals Corporation | 4 |
| Baylor College of Medicine | 4 |
| Endo USA Inc., a Keenova Therapeutics Company | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypogonadism | 213 |
| Eunuchism | 14 |
| Obesity | 14 |
| Insulin Resistance | 12 |
| Diabetes Mellitus, Type 2 | 10 |
| Erectile Dysfunction | 9 |
| Kallmann Syndrome | 9 |
| Metabolic Syndrome | 9 |
| Diabetes Mellitus | 7 |
| Endocrine System Diseases | 7 |
Trials
Showing 51 to 75 of 213. Each trial links to its page on Pharma Observatory.
113 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.